ArticleEJVES vascular forum2025
Long Term Follow Up of Abdominal Aortic Aneurysms Treated With Endovascular Aneurysm Sealing (EVAS) and Endovascular Aneurysm Repair (EVAR): A Single Centre Retrospective Cohort.
Article in EJVES vascular forum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Endovascular Aneurysm Sealing: Sealed, Signed, Disposed?EJVES vascular forum · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The Nellix endovascular aneurysm sealing (EVAS) system demonstrated promising short and midterm outcomes following its introduction in 2011. However, long term results have shown a high incidence of graft failure. This study aimed to compare the long term outcomes of EVAS compared with standard endovascular aneurysm repair (EVAR). Methods: This single centre, retrospective, comparative cohort analysis used prospectively registered data from an internal quality control registry at Innlandet Hospital Trust, Hamar Hospital, Norway. Two hundred and eighty-one patients underwent elective endovascular repair for aorto-iliac aneurysm disease between 2013 - 2016. Primary elective EVAR ( Results: Technical success was achieved in 100% of the EVAR and EVAS cases. The EVAS patients had a shorter hospital stay (3.7 Conclusion: While long term all cause mortality was comparable between EVAS and EVAR, EVAS was associated with statistically significantly higher rates of graft failure, aneurysm sac growth, aneurysm related death, and open surgical conversion. Close monitoring of new prosthetic devices in registries is essential to identify early signs of device failure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.